(19)
(11) EP 1 381 598 A1

(12)

(43) Date of publication:
21.01.2004 Bulletin 2004/04

(21) Application number: 02723631.4

(22) Date of filing: 26.03.2002
(51) International Patent Classification (IPC)7C07D 401/14, A61K 31/4184
(86) International application number:
PCT/US2002/009402
(87) International publication number:
WO 2002/079192 (10.10.2002 Gazette 2002/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.03.2001 US 279327 P

(71) Applicant: Bristol-Myers Squibb Company
Princeton, NJ 08543-4000 (US)

(72) Inventors:
  • WITTMAN, Mark, D.
    Wallingford, CT 06492 (US)
  • BALASUBRAMANIAN, Neelakantan
    Madison, CT 06443 (US)
  • VELAPARTHI, Upender
    North Haven, CT 06422 (US)
  • ZIMMERMANN, Kurt
    Durham, CT 06422 (US)
  • SAULNIER, Mark, G.
    Higgannum, CT 06441 (US)
  • LIU, Peiying
    Madison, CT 06443 (US)
  • SANG, Xiaopeng
    Glastonbury, CT 06033 (US)
  • FRENNESSON, David, B.
    Naugatuck, CT 06770 (US)
  • STOFFAN, Karen, M.
    Hartford, CT 06105 (US)
  • TARRANT, James, G.
    Hamden, CT 06518 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) NOVEL TYROSINE KINASE INHIBITORS